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ABSRACT 
Genetic Analysis of Canine Hip Dysplasia. (December 2005) 
Kate Leanne Tsai, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Keith E. Murphy 
 
 
 The morphologic variability seen in the domestic dog, Canis lupus familiaris, is 
unique among mammals. Selective pressures imposed by humans have divided dogs into 
almost 400 separate breeds. Selection has also led to the development of approximately 
450 hereditary diseases, many of which are limited to specific breeds. Over half of these 
diseases present with similar clinical characteristics to those of many human hereditary 
diseases, making the dog an ideal model for study of the genetic bases of such diseases. 
Many diseases do not have candidate genes or have too many candidates to characterize. 
This is exacerbated in complex diseases that are caused by several genes. Whole-genome 
scans can provide insight into diseases by identifying marker(s) that co-segregate with a 
disease phenotype. The Minimal Screening Set – 2 (MSS-2) is the most recent set of 
microsatellites suitable for whole-genome screens. The first objective of this work was 
to streamline genomic screens in order to efficiently analyze large numbers of animals. 
To this end, chromosome-specific microsatellite panels were developed for the MSS-2. 
 Canine hip dysplasia (CHD) is the most common orthopedic disease of the dog. 
CHD primarily affects medium and large breed dogs, but is found in almost every breed. 
The major objective of this work was to use linkage analysis to identify chromosomal 
regions that contain genes that are involved in CHD. Two populations were screened 
using the MSS-2. The first was a small family of Boykin Spaniels, though no markers 
 iv
were statistically significant in a whole-genome screen. An outcrossed pedigree of 
Greyhound/Labrador Retrievers was created for quantitative trait loci (QTL) mapping of 
CHD. The informativeness of markers in the F2 and backcrossed generations were 
calculated to show the utility of using such a population. Other factors that affect the 
power of this pedigree to identify QTL were also highlighted. Chromosomes that were 
identified in a previous screen as harboring putative QTLs were examined using the 
chromosome-specific panels to further define and confirm the regions of interest. 
Although no markers reached statistical significance, several areas of interest were 
identified. 
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CHAPTER I 
INTRODUCTION 
 
Genetics of the dog 
The morphologic variability seen in the domestic dog, Canis lupus familiaris, is 
unique among mammals and is the result of defined breeding practices carried out over 
the centuries since the dog was domesticated. Mitochondrial studies show that the 
domestic dog diverged exclusively from the wolf (Vila et al. 1997) and recent studies 
suggest that a single domestication event occurred in eastern Asia approximately 15,000 
years ago (Savolainen et al. 2002). There are now approximately 400 recognized breeds 
(FCI 2005) that have arisen due to the aforementioned selective breeding practices. Most 
breeds have come into being within the last 250 years (Ostrander and Giniger 1997) 
because breeders wanted to produce specific breeds that possess certain behavioral and 
physical traits. In the effort to propagate these specific traits, breeds have been subjected 
to a tremendous level of inbreeding. Breed clubs create a genetic barrier between breeds 
resulting in relatively isolated genetic populations that do not interbreed. However, even 
though breeds are highly differentiated, haplotype sharing shows a low level of diversity 
among all dogs (Sutter et al. 2004). In fact, breeds exhibit a high level of genetic 
homogeneity with only 27% of total genetic variation in dogs accounted for by 
variability among breeds (Parker et al. 2004).  
 
 
___________ 
This thesis follows the style of Mammalian Genome. 
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The consequence of the breed barrier and other selective pressures, such as 
limited founders, population bottlenecks, and popular-sire effects, is the emergence of 
more than 450 hereditary diseases in the dog (OMIA 2005). Many of these diseases are 
found more commonly in one particular breed or group of breeds (Patterson 2000). The 
dog has emerged as a model organism due to the fact that almost half of canine 
hereditary diseases are present in the human and many result from mutations in the same 
genes (Ostrander and Giniger 1997). Additional reasons for use of the dog as a model 
are that dogs 1) share our environment, and are therefore subject to the same external 
pressures that affect physiology, 2) receive medical attention at a level second only to 
humans, so we know more about the pathology of canine infectious and hereditary 
diseases, and 3) are physiologically more similar to the human than is the mouse. While 
many rodent models of hereditary disease are available, virtually all are induced using 
transgenics technology; the dog offers naturally occurring models of many human 
hereditary diseases. Finally, the dog has a large litter size, short generation time, and 
detailed pedigrees, making it an invaluable tool. 
 
Genomics of the dog 
The dog has 40 chromosomes, the metacentric X and Y chromosomes, and 38 
small, acrocentric autosomes that could not be distinguished from each other until the 
development of chromosome-specific fluorescence in situ hybridization (FISH) paint 
probes (Breen et al. 1999a, Breen et al. 1999b). This laid the groundwork for the 
development of a high-resolution map of the canine genome. 
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The first linkage map of the dog was developed prior to standardization of the 
karyotype and consisted of 139 microsatellite markers comprising 30 linkage groups 
(Mellersh et al. 1997). The construction of a radiation-hybrid (RH) cell panel using 
canine-hamster cell lines (Langston et al. 1997) allowed for the development of a whole 
genome RH map of the dog, consisting of 400 markers, including 218 genes and 182 
microsatellites (Priat et al. 1998, Vignaux et al. 1999). The integration of the linkage and 
RH maps (Breen et al. 2001) led to the identification of microsatellite markers that were 
evenly distributed across the genome. The first set of microsatellite markers that 
provided coverage of the canine genome and was suitable for whole genome scans is 
termed the Minimal Screening Set-1 (MSS-1) (Richman et al. 2001). The MSS-1 
consists of 172 markers with an average polymorphic information content (PIC) value of 
0.74 and average spacing of 10 cM with no gaps greater than 20 cM (Richman et al. 
2001). This set is multiplexed into 48 multiplex sets to streamline whole genome screens 
(Cargill et al. 2002).  
In 2003, a RH map composed of 3,270 markers that provide 1 Mb resolution of 
the canine genome was released (Guyon et al. 2003). A subset of highly informative 
microsatellite markers was characterized to form a more comprehensive screening set 
with greater coverage than the MSS-1. The Minimal Screening Set-2 (MSS-2) is 
comprised of 327 markers, including 171 tetra-, 151 di-, and 3 tri-nucleotide repeats with 
an average heterozygosity value of 0.73 (Guyon et al. 2003). The MSS-2 has an average 
spacing of 9 Mb and no gaps larger than 17.1 Mb (Guyon et al. 2003). The most recent 
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RH map consists of 4249 markers and more clearly defines 79 regions of conserved 
segments between the canine and human genomes (Breen et al. 2004). 
The ultimate physical map is now available for the dog. The dog became the 
fourth mammalian genome to be sequenced, and this highlighted the dramatic growth of 
canine genetics within the last 6 years. The first large scale sequencing effort in the dog 
was completed by Celera Genomics. A 1.5X sequence, representing approximately 80% 
of the genome from a male standard poodle was completed in 2003 (Kirkness et al. 
2003). The National Human Genome Research Institute (NHGRI) recognized the need 
for a publicly available sequence with higher resolution (NHGRI, 
http://www.ncbi.nlm.nih.gov/genome/guide/dog/). More than 60 breeds were tested to 
determine the level of genetic homogeneity that exists within the breed. Among the dogs 
tested, a female boxer named Tasha showed the greatest homogeneity and was chosen 
for sequencing. Today, a 7.8X sequence of the dog is publicly available (Sutter and 
Ostrander 2004). The planned sequencing of nine additional breeds (with 100,000 reads) 
will allow comparison of sequence differences between breeds and will facilitate the 
construction of a single nucleotide polymorphism (SNP) map (Sutter and Ostrander 
2004). 
 
Linkage and QTL mapping in the dog 
More than half of the 450 hereditary diseases that affect the dog are transmitted 
in an autosomal recessive fashion (Ostrander and Kruglyak 2000), making identification 
of carriers difficult. Also, many hereditary diseases have a late onset, making it difficult 
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for breeders to prevent the spread of disease alleles. There are different approaches being 
utilized to identify deleterious genes of the dog. The first approach is candidate gene 
analysis, which focuses on specific genes that are thought to be involved in the disease 
process. These candidates are often identified as causative genes in other species with a 
similar disease phenotype.  
Two other approaches, classical linkage and linkage disequilibrium (LD), are 
recombination mapping strategies that are useful when no, or many, candidate genes 
exist for a disease. Both utilize meiotic recombination to define a region that is co-
inherited, or linked, with a disease gene. Linkage analysis uses multigenerational 
pedigrees to trace inheritance of chromosomal segments harboring the causative gene. In 
the dog, it is often possible to collect phenotype information and DNA samples from 
pedigrees. When samples cannot be acquired from family members, unrelated dogs can 
be used in a LD mapping approach, which measures co-segregation at the population 
level. LD mapping assumes that the disease is the result of an ancestral mutation and is 
the same in all individuals with the trait. LD is 20-100 times more extensive in the dog 
as compared to the human, with values ranging from less than 1 Mb to greater than 3 Mb 
in different breeds (Sutter et al. 2004). Therefore, fewer markers are needed to identify a 
locus in LD. 
The above analytical tools are suitable for dissection of simple, Mendelian 
diseases, but many diseases and traits are complex. Complex traits are governed by the 
interaction of several genes and the environment, presenting an additional challenge to 
investigators. Specifically, the mode of inheritance and number of genes involved in a 
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trait are often unknown. One approach to dissecting such traits is quantitative trait loci 
(QTL) analysis. Ideally, QTL analysis is carried out using two inbred lines that express 
opposite extremes of a phenotype with each line assumed to be homozygous for the 
genes of interest. Upon breeding the two lines and creating a backcrossed generation, 
polymorphic markers can be analyzed for segregation with the trait of interest (Ostrander 
and Giniger 1997, Lynch and Walsh 1998). 
 
Hip dysplasia in the dog 
Pathogenesis  
Canine hip dysplasia (CHD) is the most common orthopedic disease of the dog. 
Clinical signs associated with CHD include lameness, a bunny-hop gait, difficulty rising, 
and reluctance to jump. It is often a biphasic disease with symptoms showing at the 
beginning of the disease in a puppy and again when the pain of arthritis begins later in 
life. 
CHD is a degenerative disease characterized by malformation of the hip joint. 
The inevitable result of CHD is osteoarthritis (OA), also termed degenerative joint 
disease (DJD). Changes in hip joint laxity and conformation begin in the first few weeks 
after birth. Lesions on the round ligament of the femoral head may be observed as early 
as 30 days of age (Morgan and Stevens 1985). It is unknown if changes in tissue 
surrounding the hip joint lead to increased laxity or if increased laxity causes tissue 
changes. Laxity in the joint allows the head of the femur to contact the edge of the 
acetabulum (Lust 1997). The joint capsule becomes inflamed causing it to thicken and 
 7
the amount of synovial fluid in the joint increases, a condition called synovitis (Lust and 
Summers 1981). Mild arthritis develops often leading to the first clinical signs of 
lameness. The joint then undergoes cartilage fibrillation and erosion, exposing the head 
of the femur and the acetabular cup, causing the bones to eburnate and resulting in 
inflammation (Fries 1995). Osteophytes form around the rim of the acetabular cup in an 
attempt to restore the articular surface (Morgan and Stevens 1985).  
 
Diagnosis and Prediction 
Several methods have been developed in an attempt to predict the probability of a 
dog developing CHD. In young dogs, hip joint laxity can be determined using the 
Bardens, Barlow and Ortolani tests (Barlow 1962, Bardens 1973, Ortolani 1976). These 
semi-quantitative tests will generally not give positive results in older dogs with 
advanced hip dysplasia due to structural changes in the joint. The only definitive manner 
to diagnose CHD is by observation of arthritis in the hip joint; although, it is important 
to note that arthritic changes may be the result of something other than CHD. In addition 
to diagnostic methods there are several radiographic techniques that predict the 
likelihood of developing CHD, including the ventrodorsal hip extended (VHE) view 
(Rendano and Ryan 1985), the University of Pennsylvania Hip Improvement Program 
(PennHip) method (Smith et al. 1990), and the dorsolateral subluxation (DLS) test 
(Farese et al. 1998). 
In an effort to reduce CHD in all breeds, the Orthopedic Foundation for Animals 
(OFA) in Missouri maintains a database of hip scores that breeders can access. The 
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scores are based on a 7-level scale that classifies hips as normal (excellent, good or fair), 
borderline, or dysplastic (mild, moderate or severe) using VHE radiographs. 
Radiographic evidence of DJD as well as the fit of the femoral head in the acetabulum 
determines the score. Similar scales exist in other countries, each with its own grading 
system (Willis 1994). Preliminary evaluations can be done when the puppy is four 
months of age but cannot completely rule out the disease until two years of age (Smith 
1993). The ventrodorsal view (with hips either extended or flexed) is used to calculate 
the Norberg angle, which is an indicator of subluxation in the hip (Norberg 1962). 
Joint laxity can cause instability of the hip leading to incomplete or complete 
dislocation of the femoral head. The PennHip method quantifies passive laxity in the hip 
joint using the distraction index (DI). This method measures the level of distraction of 
the femoral head to determine the probability of developing CHD (Smith et al. 1990). 
Scores generally range from zero to one. A higher value indicates increased joint laxity 
and a higher probability of developing CHD. General diagnostic measures have been 
described with a value less than 0.3 as normal and values above 0.7 as affected (Smith 
1993). However, there are breed-specific ranges, so it seems that some breeds may have 
a tolerance for increased laxity.  
Subluxation, or partial dislocation, of the joint may be indicative of minor 
dysplasia depending on the degree of separation. The DLS test measures the percentage 
of the femoral head that is covered by the acetabulum while in sternal recumbency. 
Increased coverage increases the DLS score and indicates a decreased probability of 
developing CHD (Farese et al. 1998). 
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Genetics 
  CHD is a complex trait. The pattern of inheritance suggests that several major 
and many minor QTL may influence the phenotypic presentation of CHD (Leighton 
1997). It is thought that there are genes that increase the risk of developing CHD as well 
as some that protect against CHD. Environmental influences also have a major effect. 
For example, caloric intake has been shown to aggravate pre-disposed dogs (Olsson 
1980).  
While it is known that joint laxity plays a major role in the development of CHD 
(Henricson et al. 1966, Kealy et al. 1997), there is some question as to whether the laxity 
leads to development of CHD or unstable hips lead to increased laxity. Smith et al. 
(1990) identified joint laxity as a heritable trait in the German Shepherd Dog. Studies of 
the genetics underlying joint laxity and overt CHD include breeding programs in 
military working dogs and designed pedigrees (Leighton et al. 1977, Todhunter et al. 
1999), as well as studies of natural populations with a high incidence of CHD (Wang et 
al. 1999, Chase et al. 2004).  
One major study is being carried out at the James A. Baker Institute for Animal 
Health at Cornell University. Researchers there maintain an outcrossed canine pedigree 
of Greyhounds and Labrador Retrievers ideal for whole genome scans (Todhunter et al. 
1999, Todhunter et al. 2003). The Greyhound is known for its sound hips, with a DI 
range of 0.07 to 0.35 (PennHip 2002). In contrast, the Labrador Retriever is prone to 
CHD, with a DI range of 0.08 to 1.36 (PennHip 2002). A screen carried out at the 
Marshfield Clinic Center for Medical Genetics on select members of the 
 10
Greyhound/Labrador Retriever pedigree allowed for the identification of several putative 
QTL spanning 12 chromosomes (Todhunter et al. 2005). In addition, the Baker Institute 
also maintains a multigenerational pedigree of Labrador Retrievers that segregate CHD. 
Our laboratory has been working with another breed, the Boykin Spaniel (BS), for quite 
some time (Wang 1990). The BS has a high level of genetic homogeneity due to its 
small, highly inbred population. Importantly, despite its small size (30-40 lbs) the BS 
has one of the highest incidences of CHD, ranking 9th of 137 breeds included in the OFA 
database (OFA).  
CHD does not seem to be predisposed to a certain gender or hip. However, Chase 
et al. detected a higher level of joint laxity in the left hips of Portuguese Water Dogs 
(PWDs) using the Norberg angle (Chase et al. 2004). They also report the identification 
of two QTL on CFA01 that asymmetrically affect joint laxity in the right or left hip of 
the PWD (Chase et al. 2004). The same group identified a marker on CFA03 that is 
associated with osteoarthritis (Chase et al. 2005). 
 
Human Hip Dysplasia  
Human hip dysplasia, or developmental dislocation of the hip affects between 1 
and 10 per 1000 live births (Weinstein 1987) and is influenced by both genetic and 
environmental factors (Carter 1964). Almost 50% of babies born with lax hips are 
naturally corrected within one week (Barlow 1962). It is more common in females, 
breech births, and firstborn children. There also seems to be prevalence for the left hip. 
Initial diagnosis generally made at birth by use of the Ortolani sign. Further investigation 
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is then done with radiographs and/or ultrasound (Grissom and Harcke 1999). The 
condition can be corrected by fixing legs in a harness (Pavlik harness) that flexes and 
abducts the legs.   
 
Specific objectives 
The objective of this work is to use linkage analysis to identify QTL that affect 
the joint laxity, the major factor influencing the development of CHD. To accomplish 
this goal, a tool that streamlines whole genome screens must be developed and 
populations suitable for analysis must be identified. To this end, chromosome-specific 
multiplex sets for the MSS-2 were developed to increase the ease and speed of linkage 
analysis. Two populations segregating CHD were identified for study, the BS and a 
designed outcrossed pedigree of Greyhound/Labrador mixes. Finally, linkage analysis 
was carried out on both populations to identify markers that co-segregate with joint 
laxity or CHD. 
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CHAPTER II 
CHROMOSOME-SPECIFIC MICROSATELLITE MULTIPLEX SETS FOR 
LINKAGE STUDIES IN THE DOMESTIC DOG*
 
Overview 
To expedite linkage studies and positional cloning efforts in the dog, Minimal 
Screening Set 2 (MSS-2) of 327 canine microsatellite markers has been multiplexed into 
chromosome-specific panels. MSS-2 provides 9 Mb coverage of the canine genome with 
no gaps larger than 17.1 Mb and is the most recent and comprehensive set of 
microsatellites available for whole-genome scans. Markers were labeled with fluorescent 
dyes based on locations and expected product sizes to facilitate the multiplexing of a 
maximum number of markers for each chromosome. All markers are amplified using a 
single thermal cycling program and PCR mix and are optimized for resolution on an ABI 
3100 genetic analyzer. Sixty-nine chromosome-specific panels were created by 
coamplification of a maximum number of markers and subsequent coloading of the 
remaining markers.  
 
 
 
  
___________ 
* Reprinted from Genomics, 84, Clark LA, Tsai KL, Steiner JM, Williams DA, Guerra T, Ostrander EA, 
Galibert F, and Murphy KE, Chromosome-specific microsatellite multiplex sets for linkage studies in the 
domestic dog, 550-554 (2004), with permission from Elsevier. 
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Introduction 
Studies of the dog offer insight into the genetic bases for many hereditary 
diseases affecting both canine and human populations (Ostrander and Kruglyak 2000; 
Ostrander et al. 2000; Patterson 2000). Linkage analyses and linkage disequilibrium 
studies are useful for eventual identification of mutated alleles in the dog, many breeds 
of which are characterized by small founding populations, high degrees of inbreeding, 
and popular sire effects.  The creation and maintenance of multigenerational pedigrees 
offers additional advantages compared to studies using human populations. To facilitate 
linkage mapping and positional cloning studies in the dog, it is necessary to have a 
defined set of polymorphic markers that provides complete coverage of the genome. 
Previously, we multiplexed Minimal Screening Set 1 (MSS-1), a set of 172 
microsatellite markers (Richman et al. 2001) selected from a map comprising 600 
markers (Mellersh et al. 2000), into 69 reactions, thereby reducing the time, expense, 
and DNA required for whole-genome screens (Cargill et al. 2002). The most recent 
version of the canine map has 3270 markers, including 1596 microsatellite markers 
(Guyon et al. 2003). From this, a superior screening set of microsatellite markers 
providing increased density and a greater level of informativeness was developed. 
Minimal Screening Set 2 (MSS-2) comprises 327 microsatellite markers that have an 
average spacing of 9 Mb with no gaps larger than 17.1 Mb (Guyon et al. 2003). The set 
includes 171 tetra-, 151 di-, and 3 tri-nucleotide repeats with an average heterozygosity 
value of 0.73 when analyzed on a panel of unrelated purebred dogs.    
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 In the human, chromosome-specific multiplexed microsatellite sets have been 
developed to accelerate collection and analysis of data for linkage studies (Reed et al. 
1994; Lindqvist et al. 1996). However, no such sets exist for the dog. The development 
of chromosome-specific multiplex panels will allow rapid screening of those 
chromosomes presumed to harbor genes of interest as determined through comparative 
mapping and genomic sequencing. 
 
Materials and methods 
Primer pairs were synthesized by Applied Biosystems (PE Biosystems, Foster 
City, CA, USA) and forward primers were labeled with one of four fluorescent dyes: 
6FAM, NED, PET, or VIC. Previously multiplexed microsatellites (Cargill et al. 2002) 
that were labeled with 6FAM were not relabeled, and those labeled with TET and HEX 
were relabeled with VIC and NED, respectively, to retain their original dye colors. Dye 
types for new markers were chosen for even distribution across each chromosome and 
size range. Primers were diluted to 10 µM. The primer sequences and intermarker 
distances are available at www.fhcrc.org/science/dog_genome/guyon2003/guyon_data/ 
mss2.html and http://www-recomgen.univ-rennes1.fr/doggy.html. 
Optimization of multiplex sets was achieved using DNA from a Rough collie and 
further testing was conducted using a family of Boykin Spaniels. Genomic DNA was 
extracted from whole blood and buccal cells using the Puregene DNA Isolation Kit 
(Gentra Systems, Minneapolis, MN, USA). 
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  All multiplex sets were amplified with a single stepdown thermal cycling 
program: 5 min at 95°C followed by 5 cycles of 30 s at 95°C, 15 s at 58°C, and 10 s at 
72°C and an additional 30 cycles of 20 s at 95°C, 15 s at 56°C, and 10 s at 72°C, with a 
final extension of 5 min at 72°C. A single mastermix, excluding primers, was used for 
all multiplex and individual reactions. Concentrations are 0.113 units/µl Taq DNA 
polymerase (Fisher Scientific, Pittsburgh, PA, USA) with 1.5× Buffer B (Fisher 
Scientific), 4.5 mM MgCl2, 1.5× MasterAmp PCR Enhancer (Epicentre Technologies, 
Madison, WI, USA), 0.75 mM total dNTPs, and 2.8 µl water to bring the final master 
mix volume to 6.65 µl. One microliter of 50 ng/µl genomic DNA was used in each 
reaction. Primer volumes vary by multiplex (Table 1), resulting in different final reaction 
volumes and concentrations. 
Multiplex sets were first established by amplifying markers for each 
chromosome in various combinations. Once the maximum number of coamplified 
markers was achieved, the remaining markers were amplified individually and coloaded 
into a multiplex set representing individual chromosomes. Duplex sets were coloaded 
into other multiplexes on the chromosome, if possible. For ease of genotyping, no 
markers having the same dye type and product sizes less than 50 bp apart were 
multiplexed in a chromosome panel. 
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Table 1: Chromosome-specific panels for the MSS-2, listed by multiplex namea followed by marker name,b primer amount,c and 
fluorescent labeld 
1.1 FH3413 0.8 P REN112I02 0.8 V C01.424 0.8 F C00901 0.8 P FH2793 0.6 P FH2326 1.0 N    
1.2 FH3325 0.8 P FH3300 0.8 N C01.251 0.8 N FH2309 0.8 V REN143K19 0.6 V       
1.3 FH2663 1.1 F FH3603 1.5 F FH3922 1.1 F FH2294 0.3 N          
2.1 FH3210 0.8 P REN303H07 0.8 V REN70M14 0.8 V FH3965 0.8 F          
2.2 FH2890 0.4 N C02.609 0.6 P FH2613 0.6 V FH2132 0.6 F          
2.3 FH2274 0.8 N FH2608 0.8 P C02.342 0.8 F             
3.1 REN161A12 0.6 F FH3252 0.6 P FH3464 0.6 V FH2316* 0.8 N FH3377 0.6 N       
3.2 FH3115 0.8 N C03.629 1.2 V FH2145 0.8 P REN260I04 0.6 F          
3.3 FH3396 1 F FH2302 0.6 V                
4.1 REN298N18 0.4 P REN303C04 0.4 V FH2732 0.8 F FH3310 0.8 F REN74B13 0.6 V AHT103 0.8 F    
4.2 FH2776 1.0 P REN195B08 0.8 N FH2097 0.6 N G07704 0.6 V          
5.1 FH3004 0.8 F DTR05.8 0.8 N FH3978 1.0 P REN175P10 0.6 V CPH14* 0.8 N       
5.2 FH3928 0.8 P FH3320 0.6 N FH3702 0.8 F FH3089 0.8 V          
5.3 FH2140 0.8 P REN285I23* 0.8 V FH3278 0.8 P C05.771 0.6 V          
6.1 FH2525 0.8 V FH2561 1.4 N FH2734  0.8 V FH2164* 0.8 V FH3303 0.5 P       
6.2 FH2576 0.6 F FH3933 0.8 P FH2370 0.8 N             
6.3 REN285H12 0.8 F FH2119 0.8 N REN111L07 0.8 P             
7.1 REN97M11 0.8 P FH3972 0.6 N REN162C04 0.8 V REN143L20 0.6 P FH2860 0.4 V       
7.2 FH2226 0.8 N VIASD10 0.8 P FH2973 0.8 P             
8.1 FH3241 0.8 P REN204K13 0.8 N FH3316 0.8 V C08.618 0.8 F          
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Table 1: Continued 
8.2 FH3425 0.8 N C08.410 0.8 F REN178J05 0.6 F FH2989 1.0 V          
9.1 GALK1 0.6 V FH2263 0.8 N C09.173 0.4 N REN54L20 0.4 F G06401 0.6 P REN287G01 0.6 N    
9.2 FH2186 1.4 V REN145P07 0.6 P FH3835 0.3 F REN73K24 0.3 V FH2885 0.4 N       
10.1 FH2537 0.8 N FH4081 0.8 P C10.781 0.6 V ZUBECA1 0.4 N DTR10.5 0.8 F FH3381* 0.8 P    
10.2 REN06H21 0.8 P FH2293 0.8 V C10.16 0.8 F FH2422 0.8 N          
11.1 FH3203 0.8 V REN242K04 0.8 F FH2004 0.6 F C11.868 0.8 P C11.873 0.8 V DGN13 0.8 V    
11.2 AHT137 0.3 V FH4031 0.8 P FH2319 1.0 N FH2019 0.2 N          
12.1 REN153O12 0.6 F FH2401 0.6 V FH3591 0.6 N G01811 0.6 P REN94K11 0.6 N       
12.2 REN258L11 0.8 P REN213F01 0.8 F FH3711* 0.8 N FH1040 0.6 V FH3748 0.8 P       
13.1 C13.391 0.8 N FH3494** 0.8 V REN120P21 0.6 F FH3619 0.6 P DTR13.6 0.6 F FH2348 1.2 V REN227M12** 0.8 P
 FH3800 0.6 N                   
14.1 FH3951 1 F FH3725 0.6 P FH2658 1 P FH2763 0.4 N          
14.2 C14.866 0.8 F FH3285 0.8 P PEZ10 0.8 V             
15.1 FH4012 0.6 P FH3813 0.8 V FH2171 0.6 N CPH4 0.8 N REN230G12 0.6 F       
15.2 FH3802 0.6 V REN06C11 0.6 F FH2360 0.8 P             
16.1 REN214L11 0.4 V FH2670 0.6 F REN73O19 0.6 P REN85N14 0.8 P FH3592 0.8 V       
16.2 FH2155 1.0 N REN275L19 0.4 N FH2175 1.2 F             
17.1 REN240A05 0.6 F FH3369 0.6 P REN294E18 0.6 V FH3995 0.8 F          
17.2 FH3047 0.8 P FH4023 0.8 P PEZ8 1.0 N FH2869 0.6 V          
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Table 1: Continued 
               
18.1 FH4060 1.0 N FH3944* 0.8 P FH3824 0.4 V FH3815 0.4 F REN54P11* 0.8 P FH2834 0.4 N REN47J11* 0.8 V
 AHT130 0.6 F                   
19.1 REN213G21 0.6 V FH3491 0.4 F FH3313 1.0 P FH2206* 0.8 P FH2380 0.6 N       
19.2 FH3299 0.6 V FH3834 0.6 F FH3969 0.6 N             
20.1 PEZ19 0.8 N FH2951 0.6 F FH2158 1.0 P REN114M19 0.4 F          
20.2 REN55P21* 0.8 N REN100J13 0.8 P REN93E07 0.2 V AHTk209 1.0 N          
21.1 FH3803 1.0 P FH2233** 0.8 F REN118B15 0.3 V FH2441 0.8 N REN37A15 0.3 V FH3398 0.8 P FH2312** 0.8 N
22.1 REN42F10 0.8 V FH3355 0.8 V FH3411 0.8 N FH3853 0.8 P          
22.2 REN49F22 1.0 N REN128E21 1.0 P C22.279 0.4 V REN78I16 0.6 F          
23.1 FH3078 0.8 P FH2508 1.0 P FH2626 0.8 F REN113M13 0.6 V REN02P03 0.8 N REN181K04 0.8 P    
24.1 FH3023 0.8 P FH2261* 0.8 F AHT125 0.8 P FH3287 0.8 F REN228J19 0.8 V       
24.2 FH3750 0.8 P FH2159 0.8 N REN106I06 0.6 V REN272I16 0.4 F          
25.1 REN54E19 0.8 F FH3245* 0.8 P FH2324 0.3 N FH2141 1.0 N FH3627 0.3 V FH4027 0.7 F    
26.1 REN62M06 0.4 N DTR26.9 0.4 V FH3426 0.4 V DGN10* 0.8 P FH2130 1.0 N C26.733 0.6 F    
27.1 FH3221 0.8 P PEZ6 0.6 F REN181L14 0.4 N REN72K15 0.4 V          
27.2 FH2289 0.8 P PEZ16 0.3 N LEI002 0.3 F FH3924 0.6 V          
28.1 C28.176 0.8 V FH3963 0.8 P FH2585 0.8 F REN146G17 0.8 V FH2208* 0.8 N       
29.1 FH2952 0.8 P FH2364* 0.8 F REN52D08 0.4 P REN45F03 0.8 F FH2385 1.0 V FH1007 0.3 V    
30.1 FH3489 0.4 F REN51C16 0.4 P REN248F14** 0.8 V FH2290 1.0 N FH3632** 0.8 P FH3053 0.4 F    
31.1 FH2189 0.8 N RVC11 0.6 V REN43H24 0.6 N REN109B10 1.2 P REN110K04* 0.8 P FH2712 0.4 F    
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Table 1: Continued                 
 
32.1 REN244E04 0.3 F CPH2 0.4 V FH2875 0.6 N FH3635 1.0 F FH3236 0.8 N AHT127 0.3 V FH3294* 0.8 P
33.1 FH2790 0.4 F FH3608 0.8 F FH2361 0.3 V REN186B12 0.6 V FH2165* 0.8 N       
34.1 FH3721 0.8 P REN174M24 0.6 F REN243O23 0.8 F REN314H10 0.4 V          
34.2 REN109L16 0.8 N FH2377 0.8 V FH3836 0.8 N             
35.1 FH3570 0.8 F REN282I22 0.4 V REN94K23 0.6 N REN112C08 0.6 P          
36.1 REN106I07 0.8 V FH2611 0.8 P REN179H15 0.8 P FH3865 0.8 V DTR36.3* 0.8 N       
37.1 FH3272 0.8 F H10101 0.8 V REN67C18 0.8 P FH3449 0.8 F FH2532 0.8 N       
38.1 FH2766 0.8 P REN02C20 0.8 F REN164E17 0.8 N             
X.1 FH2916 0.8 F REN101G16 1.0 N D04614 0.8 F REN144O22 0.6 V          
X.2 FH3027 0.8 N FH1020 0.8 F FH2985 0.6 N REN230I20 0.6 V          
X.3 REN130F03 0.8 F FH2584 0.8 N REN75A05 0.8 P             
Y.1 REN197E16 0.8 V REN44K10** 0.6 F DTRY.13** 0.4 F REN75H09 0.2 V REN173O16 0.2 P       
a Denoted by chromosome and then multiplex number within chromosome 
b Marker names; * indicates that the marker is amplified individually and co-loaded into the panel; ** indicates that the markers are co-amplified  
  and then co-loaded into the panel. 
c Total amount (µl) of primer (forward and reverse) in the multiplex.  
d F=6FAM, P=PET, V=VIC, N=NED 
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PCR products were diluted 1:20 with water and resolved with an internal size 
standard (GeneScan 500 LIZ, PE Biosystems) using an ABI 3100 capillary-based 
genetic analyzer (PE Biosystems). For coloading, dilutions of 1:10 were made for the 
multiplex and combined with dilutions of 1:20 for the coloaded marker. Analysis of 
multiplex sets was done using ABI GENESCAN version 3.7 (PE Biosystems). 
 
Results 
Three hundred sixteen microsatellite markers from MSS-2 are resolved in 69 
chromosome-specific panels (Table 1), providing an average of 1.73 multiplex sets per 
chromosome. Two hundred ninety-six markers can be coamplified within the 
chromosome panels. The remaining 20 markers are amplified individually and coloaded 
into designated panels for resolution in a single capillary. Eight markers are coamplified 
in pairs and are then coloaded with the appropriate panel. Three markers, FH3245, 
REN51i12, and, FH2239, could not be coamplified or coloaded in chromosome-specific 
fashion and must be resolved individually. 
All multiplexed markers are amplified using a single PCR mix and thermal 
cycling program. For multiplexing, 78 primers were labeled with 6-FAM, 82 with VIC, 
82 with NED, and 85 with PET. In multiplexes 7.1, 9.1, 12.2, 23.1, and 37.1, two 
markers with the same dye type have similar product sizes. Eight markers, REN262G24, 
REN286O18, FH3970, FH2200, REN297D17, FH3939, REN89K14, and FH3399, did 
not amplify or were not able to be genotyped using these parameters and, hence, were 
not incorporated into the chromosome-specific panels described here.  
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Discussion 
The most comprehensive screening set currently defined for linkage studies in 
the dog is MSS-2, which offers 9 Mb coverage and highly polymorphic markers, 
including 64 markers from the MSS-1. To enhance the utility of MSS-2, we have 
developed chromosome-specific multiplex sets, which expedite whole genome scans in 
the dog and have the potential to exclude candidate genes on a given chromosome. 
Collection of data by chromosome also allows for statistical analysis for individual 
chromosomes to be conducted before the whole genome scan is complete and will 
facilitate confirmation of linkage studies, as well as positional cloning efforts. 
The multiplex sets minimize the expense, time, and genetic material necessary to 
collect genotype information for MSS-2. The number of reactions and runs on a genetic 
analyzer are reduced by 68% and 76%, respectively. Collection of data is further 
streamlined through use of a single thermal cycling program and PCR mix. To increase 
the ease with which alleles can be determined, markers having the same dye type and 
product sizes separated by less than 50 bp were not combined in the same panel. 
However, similar product sizes from markers having the same dye type were observed in 
multiplexes 7.1, 9.1, 12.2, 23.1, and 37.1 and alternate dye-types could be selected to 
eliminate possible genotype error. Observed allelic sizes, figures of panels, overlapping 
markers, and suggested primer labels are available at www.cvm.tamu.edu/cgr/ 
multiplex.html. 
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CHAPTER III 
CLINICAL AND GENETIC ASSESSMENTS OF HIP JOINT LAXITY IN THE 
BOYKIN SPANIEL 
 
Overview 
Canine hip dysplasia (CHD) is characterized by a malformation of the hip joint 
that leads to joint laxity and consequential degenerative joint disease. The most widely 
used method for diagnosis of CHD is the ventrodorsal hip extended view, commonly 
referred to as the OFA method. An alternative technique, PennHIP, is based on hip joint 
laxity and provides a quantitative assessment, the distraction index (DI), regarding the 
likelihood of developing CHD due to increased laxity in the hip joint. Linear regression 
showed that the incidence of CHD is positively correlated with the mean DI. In an effort 
to better understand joint laxity and hip dysplasia, we utilized families of Boykin 
Spaniels (BSs) to determine the level of joint laxity in the breed and to conduct an initial 
whole genome screen to identify markers that co-segregate with marked joint laxity.  
 
Introduction 
The BS originated in South Carolina in the early 1900s and is now found 
throughout the United States, although the majority of the population is still found in and 
around the Carolinas. The BS is relatively small in size, weighing between 25 to 40 lbs, 
yet has a surprisingly high incidence of hip dysplasia as reported by the Orthopedic 
Foundation for Animals (OFA; http://www.offa.org).  From a genetic standpoint, the BS 
 23
has a high level of genetic homogeneity based on analysis of randomly amplified 
polymorphic DNA (Wang et al. 1999).  
CHD is the most common orthopedic disease of the dog. It is a degenerative 
disease characterized by malformation of the hip joint. The inevitable result of CHD is 
osteoarthritis, also termed degenerative joint disease (DJD). The presence of 
osteoarthritic changes is the primary diagnostic criterion for CHD. The most common 
radiographic tests used for diagnosis of CHD are the OFA method and the PennHIP 
(University of Pennsylvania Hip Improvement Program) method (Smith et al. 1990). 
The OFA maintains a registry of dogs that have been radiographed using the 
ventrodorsal hip-extended view to diagnose the presence of CHD. A panel of 
radiologists scores radiographs on a 7-point scale. Prior to 1980, radiographs had been 
submitted to the OFA for only 38 BSs, with almost 40% of those dogs classified as 
dysplastic and none earning an excellent rating. Over 1,400 BSs were evaluated by OFA 
between 1974 and 2003. Less than 1% were scored as excellent, while approximately 
40% were scored as dysplastic. In summary, the BS has the 9th highest incidence of hip 
dysplasia according to the OFA. The PennHIP method uses joint laxity to predict future 
development of CHD. Joint laxity can cause instability of the hip leading to incomplete 
or complete dislocation of the femoral head. The PennHIP method quantifies passive 
laxity in the hip joint by measuring the DI, which is the distance of the femoral head 
from the center of the acetabulum divided by the radius (Smith et al. 1990). A higher DI 
is indicative of a higher probability of developing osteoarthritis, as a result of CHD. 
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According to the PennHIP registry, the BS has the 12th highest mean distraction index of 
0.64 (PennHip 2002). 
CHD is a complex trait with both quantitative trait loci (QTL) and environmental 
factors contributing to the phenotype (Henricson et al. 1966; Leighton et al.1977; 
Hedhammar et al. 1979). The pattern of inheritance of CHD suggests that several major 
and minor QTL may influence the phenotypic presentation of CHD (Leighton 1997). 
Studies of the genetics underlying joint laxity and overt CHD include breeding programs 
in military working dogs and designed pedigrees (Leighton et al. 1977; Todhunter et al. 
1999). Additionally, using the German Shepherd Dog, Smith et al. identified joint laxity 
as a heritable trait (Smith et al. 1990). Hip dysplasia in the human occurs more often in 
the left hip (Smith et al. 1963), but this trend has not been observed in the dog. However, 
Chase et al. detected a higher level of joint laxity in the left hips of Portuguese Water 
Dogs (PWDs) using the Norberg angle (Chase et al. 2004). They also report the 
identification of two QTL on CFA01 that asymmetrically affect joint laxity in the right 
or left hip of the PWD (Chase et al. 2004). 
A linkage analysis approach is often taken to identify regions of the genome that 
co-segregate with a disease gene(s). This allows for the identification of candidate genes 
when there are none, or the narrowing of candidate genes if many exist. Microsatellite 
markers have become the tool of choice for linkage analyses due to their polymorphic 
nature and Mendelian inheritance. Microsatellites are tandem repeats of one to six base 
pairs that are dispersed throughout the genome.  In the dog, the minimal screening set – 
2 (MSS-2) is the most comprehensive screening set of microsatellite markers available 
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for use in whole genome scans. The MSS-2 is comprised of 327 microsatellite markers 
that have an average heterozygosity value of 0.73 and an average spacing of 9 Mb with 
no gaps larger than 17.1 Mb (Guyon et al. 2003). The MSS-2 has been multiplexed into 
69 chromosome-specific panels to expedite whole genome screens (Clark et al. 2004). 
To identify markers that co-segregate with increased joint laxity, a whole genome screen 
utilizing the multiplexed MSS-2 was carried out on a small pedigree of BSs.  
 
Report 
Because many BSs have been examined using the OFA method and work 
reported here used the PennHIP method, it was of interest to define the relationship 
between CHD and joint laxity. Correlation between the OFA and PennHip methods has 
previously been defined. However, the criteria used are different between studies. For 
example, Adams et al. found a correlation between the DI and DJD, but not for DI and 
CHD as these conditions were classified (Adams et al. 2000). We wanted to define the 
correlation between DI and CHD based on the OFA definition of clinical dysplasia. 
Therefore, linear regression analysis was performed across 96 breeds to compare the 
incidence of hip dysplasia as defined by the OFA, to the degree of joint laxity as defined 
by PennHIP. Only breeds having 100 or more evaluations from 1974 to 2003 in the OFA 
registry and were represented by 20 or more dogs in the 2002 PennHIP registry were 
included. This analysis showed a positive correlation between the mean DI and the 
percentage of dysplastic dogs, as determined by the OFA assessment (Figure 1). The 
determination coefficient of OFA CHD incidence and the mean PennHIP DI is 0.26. 
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Although the BS is a relatively small breed, the breed is among the top ten most 
dysplastic breeds according to OFA. The PennHIP method offers a possible explanation 
for this. That is, the high degree of joint laxity in the BS predisposes the breed to CHD. 
Hence, the incidence of CHD as determined by the OFA method is increased in this 
breed. 
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Figure 1. Linear regression analysis of the percent of dysplastic dogs in the OFA 
registry as compared to the mean DI for each breed. 
 
We have assembled partial, multigenerational pedigrees of BSs that segregate 
CHD. DNA and PennHIP data were previously collected for each family member (Wang 
et al. 1999). DIs greater than 0.60 were considered affected phenotypes. The MSS-2 
reactions were set up as described in Clark et al. for 28 BSs (Clark et al. 2004). Products 
were resolved using a capillary-based genetic analyzer (ABI 3100; PE Biosystems). 
Genotypes were analyzed using a commercial software program (Genotyper version 2.0; 
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PE Biosystems). Two-point LOD (Logarithm of the Odds) scores were calculated for 
each marker using a statistical software package (Sequential Oligogenic Linkage 
Analysis Routines, SOLAR; Southwest Foundation for Biomedical Research). LOD 
scores were calculated for the left and right hips separately, as well as together. 
The average DI for the 28 genotyped dogs was 0.55. Genotypes were collected 
for 272 markers. Thirty-seven markers (14%) were non-informative, having only one or 
two alleles. LOD scores were calculated for 254 markers. Marker FH3413, located on 
CFA01, had the highest LOD score of 1.23. This LOD score was correlated with 
increased laxity in the right hip joint. A LOD score of 3.0 or greater is necessary to infer 
linkage. It is interesting that LOD scores for the left or right hip individually varied for 
many markers and that the highest LOD was found on the same chromosome that was 
identified by Chase et al. Although there was a positive correlation between the 
incidence of hip dysplasia and increased joint laxity, we did not find significant linkage 
in the BS. This is very likely due to the small size of the pedigree. Additional pedigree 
members and/or increased marker density are necessary to identify a region of interest.  
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CHAPTER IV 
ANALYSIS OF ALLELE FIDELITY, POLYMORPHIC INFORMATION 
CONTENT, AND DENSITY OF MICROSATELLITES IN A GENOME WIDE 
SCREENING FOR HIP DYSPLASIA IN A CROSS BREED PEDIGREE* 
 
Overview 
Recent advances in genomics resources and tools are facilitating quantitative trait 
locus mapping. We developed a cross breed pedigree for mapping QTL for hip dysplasia 
in dogs, by crossing dysplastic Labrador Retrievers and normal Greyhounds. We show 
that one advantage of using a cross breed pedigree is the increased marker 
informativeness in the backcross/F2 population relative to the founder populations. We 
also discuss 3 factors that affect the detection power in the context of this cross breed 
pedigree: ability to detect and correct genotyping errors, increasing marker density for 
chromosomes with a sparse coverage, and addition of individuals to the mapping 
population as soon as they become available. 
 
 
 
 
 
___________          
* Reprinted from Mateescu RG, Zhang Z, Tsai K, Phavaphutanon J, Burton-Wurster NI, Lust G, Quaas R, 
Murphy K, Acland GM, and Todhunter RJ (2005) Analysis of allele fidelity, polymorphic information 
content, and density of microsatellites in a genome wide screening for hip dysplasia in a cross breed 
pedigree. Journal of Heredity (in press) by permission of Oxford University Press 
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Introduction 
Our interest is in the clinical characterization and genetic basis for canine hip 
dysplasia (CHD). To dissect the underlying genetics of this common heritable trait in 
dogs, an experimental pedigree was established in 1994 by crossing unaffected 
Greyhounds and dysplastic Labrador Retrievers. This pedigree includes over 150 dogs 
spanning four generations of backcrosses and intercrosses (Todhunter et al. 1999, 
Todhunter et al. 2003). Clinical assessment of hips is determined using multiple 
diagnostic approaches when dogs are 4 and 8 months of age (Bliss et al. 2002, Lust et al. 
2001). A genome-wide screen was undertaken on this cross breed pedigree in 
collaboration with the Mammalian Genotyping Service, Marshfield, WI. At the time of 
this undertaking, Minimal Screening Set 1 (MSS1) of 172 markers (Richman et al. 2001) 
and the canine genetic map of 2001 (Breen et al. 2001) were used to develop a 240-
marker set for the aforementioned screen with microsatellite markers to be resolved 
using a gel-based system.   
The identification of genes contributing to variation in canine hip dysplasia 
requires genetic data of high fidelity. The genotypes on 147 cross breeds at 247 loci 
were assessed for correct Mendelian inheritance patterns and repeatability. Genotyping 
errors occur when the observed genotype does not correspond to the true underlying 
genetic information, as a result of a mistake in data entry or a misinterpretation of the 
pattern on a gel. Even a small number of genotyping errors can have negative 
consequences, increasing the estimated recombination fraction (Terwilliger et al. 1990) 
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and reducing the evidence for linkage (Abecasis et al. 2001; Goring and Terwilliger 
2000).  
In this report, we describe the method used to identify reading errors in marker 
allelic size and the approach taken to correct such errors. A comparison of the 
microsatellite informativeness between the pure breeds and the cross breed dogs is also 
presented. We further show, using one chromosome as an example, the effect on QTL 
mapping resolution of correcting genotyping errors, of including additional markers and 
of adding more dogs to the analysis. 
 
Materials and methods 
Pedigree 
Seven Greyhounds (2 males and 5 females) with excellent hip conformation 
chosen from racing stock along with 7 Labrador Retrievers (3 males and 4 females) with 
hip dysplasia and secondary hip osteoarthritis and one female Labrador Retriever with 
an intermediate phenotype but from a dysplastic lineage were selected as founders for 
our pedigree (Todhunter et al. 1999). The Greyhound (G) is one of the few breeds in 
which hip dysplasia is rare as evidenced by hip joint conformation consistently scored as 
“perfect” (Beling et al. 1975) or “normal” (PennHIP™ hip registry, Malvern PA) 
(Cardinet GH et al. 1983). The Greyhound founders were assumed to be homozygous for 
alleles protective against hip dysplasia and the dysplastic Labrador Retrievers were 
assumed to be homozygous at the loci contributing to hip dysplasia for statistical 
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mapping purposes. The cross breed pedigree consists of 4-generations (G and L founders, 
F1, backcrosses to both founders, and F2 individuals) comprising 159 dogs. 
 
DNA and Genotyping 
DNA was isolated from peripheral blood by phenol-chloroform extraction. Gel-
based electrophoretic separation was used to size microsatellite alleles at the NHLBI 
Mammalian Genotyping Service, Marshfield Medical Research Foundation, Marshfield, 
WI (Weber and Broman 2001) and capillary electrophoresis was used at Cornell 
University at the Bioresource Center on an Applied Biosystems Incorporated 3730 
sequencer.   
 
Microsatellites 
From the integrated canine genetic map (Breen et al. 2001), we selected 240 
microsatellite markers, 142 from the linkage map and 98 from the RH map (Lou et al. 
2003). Seven additional microsatellite markers were identified for CFA37 (personal 
communication with E. Kirkness, The Institute for Genomic Research, Rockville, MA). 
The most likely order and spacing of markers on this chromosome were calculated based 
on meiotic recombination in our pedigree using multipoint analysis available from 
MULTIMAP (Matise et al. 1993). This marker set covers approximately 80% of the 
estimated length of the canine genome (2.4 Gb).   
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Allele Check 
The QTL mapping programs require marker genotype data in a pedigree to 
follow the Mendelian inheritance principles. Therefore, the first step in data editing is to 
check for Mendelian inheritance errors. We developed a program (ZZ, 
http://www.people.cornell.edu/pages/zz19/research/genoped) that checks the genotypes 
in the pedigree for inconsistencies between parents and offspring.  
 
Allele Correction 
The second step in data editing is correcting these errors. A program to 
accomplish this task (RM) identifies all possible alleles for a given marker in the grand 
parent’s generation, assumes that these alleles are measured without errors, follows each 
allele through the pedigree and checks for inconsistencies within a narrow interval. 
Finally, inconsistencies are corrected. The range was defined as ± 2 bp relative to the 
grand parent allele size for the tetranucleotide and ±1 bp for di- and trinucleotide repeat 
microsatellites. These errors were corrected by calling the alleles that differ by 1 or 2 bp 
as one allele. The errors outside these ranges were left uncorrected, resulting in missing 
data. 
 
Polymorphic Information Content 
To assess the quality of marker genotype data in our cross breed pedigree, the 
total number of alleles and the mean number of alleles per locus were determined for 
each marker for the two founder groups, the F1 breeders and the BC/F2 population. The 
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differences in observed allele frequencies for pairwise comparisons between the 
Labrador Retriever and Greyhound founders were tested at each locus. Because the 
sample size is small relative to the size of markers contingency tables, a chi-square test 
may not be valid and a more appropriate test of no association would be Fisher’s exact 
test.  
The Polymorphism Information Content (PIC) for each marker was determined 
separately for the four groups of animals using the following equation: 
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where pi is the frequency of the ith allele and n is the number of alleles (Botstein et al. 
1980). 
To analyze the change in the PIC between the four different breed groups, the 
following statistical model was used: 
Yij = µ + Breedi + eij  
where  
Yij = PIC for marker j in breed i, 
 µ = overall mean,  
Breedi = breed (i = Labrador Retriever, Greyhound, F1, backcross),  
eij = error associated with ij
th observation, assumed to be normally distributed N (0, σ2e). 
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QTL Mapping 
QTL mapping was performed using a regression approach originally described 
by Haley and Knott (1992). A web-based version of this tool is available (Seaton et al. 
2002). The software, QTL Express (http://latte.cap.ed.ac.uk/), analyzes data from 
different mating schemes including the combined backcross/F2 design employed for our 
cross breed pedigree. Hip traits measured and analyzed included the distraction index 
(DI, a measure of hip laxity), the dorsolateral subluxation (DLS) score and the Norberg 
angle. Chromosome-wide significance thresholds for each trait were determined 
(Churchill and Doerge 1994); the threshold at p<0.05 and p<0.01 was obtained from 
1000 permutations.  
 
Results 
Allelic Size Error Detection 
The error rate was 4.92% (out of 36,309 genotypes) for all 247 markers (Table 2). 
The highest average error rate at 16.08% was for chromosome 37. Average error rates 
for chromosome 4, 7, 25 and 32 were > 10%. Fourteen other chromosomes had one or 
more markers with error rates > 30% (data not shown). Only chromosome 38 and the Y 
chromosomes were free of marker error. The marker with the highest error rate was 
FH2532 on CFA37 with 68% errors and this marker alone accounted for 89% of all 
genotyping errors associated with this chromosome (data not shown). Tetranucleotide 
markers had a disproportionate number of errors compared to the di- and trinucleotides.  
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Table 2. Distribution of genotyping errors on initial and corrected data following a 
genome-wide screen with 247 markers on 159 dogs from a cross breed pedigree. 
 
  
Raw data 
(n=147) 
__________________________________ 
Corrected data  
(n=159) 
__________________________________ 
CFA 
__________ # markers___________________ Errors____________ Rate (%)__________________ Errors____________ Rate (%) _________________ 
1 11 54 3.5 8 0.46 
2 11 101 6.38 15 0.86 
3 9 85 6.6 22 1.54 
4 8 118 10.17 45 3.54 
5 10 40 2.83 7 0.44 
6 6 80 9.43 18 1.89 
7 10 180 12.57 15 0.94 
8 6 52 6.06 2 0.21 
9 7 37 3.65 34 3.05 
10 7 46 4.65 26 2.34 
11 7 82 8.18 20 1.80 
12 9 63 4.89 5 0.35 
13 5 1 0.14 3 0.38 
14 7 70 7.09 40 3.59 
15 7 27 2.69 2 0.18 
16 4 12 2.09 1 0.16 
17 5 29 4.18 2 0.25 
18 7 49 4.97 12 1.08 
19 5 9 1.29 9 1.13 
20 5 55 7.74 54 6.79 
21 5 51 7.31 14 1.76 
22 6 58 6.84 13 1.36 
23 6 21 2.45 3 0.31 
24 4 5 0.88 5 0.79 
25 6 95 11.14 5 0.52 
26 5 14 1.96 0 0 
27 6 13 1.50 7 0.73 
28 6 19 2.21 11 1.15 
29 4 3 0.53 3 0.47 
30 7 24 2.35 3 0.27 
31 5 5 0.69 4 0.50 
32 4 72 12.83 7 1.10 
33 5 53 7.36 10 1.26 
34 4 24 4.15 0 0 
35 4 3 0.54 0 0 
36 2 3 1.05 3 0.94 
37 13 114 16.08 0 0 
38 4 0 0 0 0 
X 5 0 0 0 0 
Total 247 1788 4.92 522 1.07 
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The error rate for each chromosome after running the Allelic Size Correction 
program is shown in Table 2. The average error rate for the corrected data was 1.07% 
and the total number of errors was reduced by 70%. All chromosomes, except CFA20, 
have an average error rate below 3% and 5 chromosomes have zero errors. 
 
Marker Informativeness 
Summary statistics for PIC, including the mean number of alleles per locus, the 
median, 25% and 75% quartiles and the range for the two founder breeds, F1 and 
backcross generations, are listed in Table 3. The marker distribution by number of alleles 
in the cross breed pedigree is shown in Figure 2. A decrease in proportion of markers 
with fewer than 3 alleles and an increase in those with more than 3 alleles is observed in 
the F1 and BC generation as compared to the two founder breeds. The increase in the 
number of alleles per microsatellite locus translates into an increase in the PIC (Table 3).  
The increased informativeness of the markers in a cross breed pedigree is one of 
the advantages of using a cross breed pedigree for linkage mapping and is associated 
with an increase in proportion of moderately and highly informative markers in F1 and 
backcross generations relative to the founders (Table 4). Approximately 60% of the 
markers in the backcross generation demonstrated high information content compared to 
only 39% in the Labrador Retriever and 48% in the Greyhound founders.  
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Table 3. Descriptive statistics including number of individuals (n), the mean and 
maximum number of alleles per marker, the median, 25% (Q1) and 75% (Q3) quartiles 
and the range for the polymorphism information content (PIC) of 247 microsatellite 
markers screened on 159 dogs in an experimental canine pedigree representing the 
Labrador Retriever (L) and Greyhound (G) founders, F1 and backcross (BC) generations. 
 
  No. of alleles 
____________________________________________
PIC 
____________________________________________________ 
 n 
_______ 
Mean/marker 
______________________ 
Maximum 
_________________ 
Median 
______________ 
Q1 
________ 
Q3 
________ 
Range 
___________ 
L 9 3.61 8 0.54 0.37 0.65 0-0.84 
G 7 4.1 9 0.58 0.39 0.70 0-0.86 
F1 7 4.3 10 0.62 0.46 0.72 0-0.88 
BC 136 5.58 16 0.63 0.46 0.71 0-0.89 
 
 
 
Figure 2. Marker distribution versus number of alleles in the Labrador Retriever (Lab) 
and Greyhound (Grey) founders, F1 and backcross/F2 (BC/F2) populations.  
         Lab   Grey         F1               BC/F2 
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Table 4. Descriptive statistics for 247 microsatellite markers in the Labrador Retriever 
(L), Greyhound (G), F1 and backcross/F2 (BC/F2) populations. 
 Range of PIC values 
 
< 0.30  
(uninformative) 
_________________________ 
0.3 - 0.59  
(moderately informative) 
_________________________________ 
> 0.60  
(highly informative) 
__________________________ 
L 37 (15.04%) 114 (46.34%) 95 (38.62%) 
G 34 (13.82%) 94 (38.21%) 118 (47.97%) 
F1 27 (10.98%) 90 (36.58%) 129 (52.44%) 
BC/F2 22 (8.94%) 76 (30.89%) 148 (60.16%) 
 
 
The differences in observed allelic frequencies for pair wise comparisons 
between the Labrador Retriever and Greyhound founders were tested at each locus. Four 
out of 247 markers (REN193A22, REN166C13, AHTH134Ren and RENo2C20) were 
monomorphic in both founder breeds. For 162 of the remaining 243 markers, the allelic 
frequencies were significantly different between the two founder populations (the Fisher 
test for 127 markers had P < 0.01 and for 35 markers had 0.01 < P < 0.05). The most 
prominent markers (with highest Fisher test statistic) were REN41D20, REN150M24, 
REN130F03, LEI002 and FH2060. We also evaluated the difference in number of alleles 
between the two founder breeds for each marker. In the Greyhounds, 24.4% of the 
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markers had up to three fewer alleles, 28% had the same number and 47.6% had up to 
six more alleles relative to the Labrador Retriever founders. 
The least square means and standard deviation for PIC in the two founder breeds, 
F1 and backcross generations are shown in Table 5. Pair wise comparison of PIC least 
squares means shows that the two founder breeds were not different (P = 0.1). However, 
PIC was significantly higher in F1 and backcross individuals (P < 0.01) relative to the 
Labrador Retriever Retriever founders and in backcross (P < 0.01) relative to the 
Greyhound founders.  
 
Table 5. Least square means (LSM) and standard deviation (SD) for PIC in the Labrador 
Retriever founders (L), Greyhound founders (G), F1 and backcross/F2 (BC/F2) 
populations.  
 
PIC 
__________________________ 
Het 
__________________________ 
 
LSM 
__________ 
SD 
_________ 
LSM 
__________ 
SD 
_______ 
L 0.50 0.19 0.55 0.20 
G 0.53 0.21 0.58 0.21 
F1 0.57 0.20 0.62 0.20 
BC/F2 0.58 0.20 0.63 0.19 
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Factors Affecting Mapping Power on CFA06 
CFA06 is used as an example to illustrate the importance of correcting genotype 
errors, of marker density and of the number of observations on the ability to detect QTL. 
Six markers covering 45.5 cM of CFA06 were initially genotyped on 147 dogs from the 
cross breed pedigree. Checking the data for Mendelian-inheritance errors, 33 and 54 
errors were identified for marker FH2164 and marker FH2561, respectively. To analyze 
the data using QTL Express, all errors were changed to missing values (QTL Express 
requires genotypes at each marker to be consistent with Mendelian inheritance). An 
interval mapping analysis was performed and the values of the F test for three traits (DI 
on the left side and DLS score on both right and left side) at each location along CFA06 
are plotted in Figure 3A. From these results, we would conclude that there is no QTL 
affecting any of these traits on CFA06.  
In the next step, errors for markers FH2164 and FH2561 were corrected using 
our Allelic Size Correction program. The 33 errors for marker FH2164 and 53 of the 54 
errors for marker FH2561 were successfully resolved. The remaining error for marker 
FH2561 is likely a mutation and, therefore, it was set as a missing value. Interval 
mapping analysis was performed again using the corrected data set and the plot of the F 
test statistic is shown in Figure 3B. Note the rise of the F test value for all 3 traits at the 
right telomeric end of the chromosome, with the F-test for the left DI trait approaching 
significance. These results suggest that a QTL around the 45 cM position might reside 
on this chromosome. Note that most of the corrected errors (53) were for FH2561 
marker which is located at 45 cM.  
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Figure 3. F-value plots for left distraction index (DI), left and right dorsolateral 
subluxation (DLS) score from interval mapping on CFA06. The position of the initial six 
markers is indicated by the solid arrows and the position of additional 7 markers by 
interrupted arrows. 
  left DI         left DLS       right DLS 
A. Mendelian-inheritance errors on markers FH2164 (33) and FH2561 (54) were 
transformed into missing values. No F statistic reached the chromosome-wide threshold 
indicated by the horizontal bar.  
B. Mendelian-inheritance errors on markers FH2164 (33) and FH2561 (54) were 
corrected. No F statistic reached the chromosome-wide threshold indicated by the 
horizontal bar, but there was an increase in F-test values at the far right end of the 
chromosome.  
C. Interval mapping after correction of Mendelian-inheritance errors on markers FH2164 
and FH2561 and addition of 7 markers. The F statistic for the 3 traits are approaching the 
chromosome-wide threshold.  
D. Interval mapping after correction of Mendelian-inheritance errors on markers FH2164 
and FH2561 and addition of 7 markers and 12 backcross individuals. The F statistic for 
the left DI and right DLS score are exceeding the threshold of significance at α = 0.05.  
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The approximate length of CFA06 is 87 cM and the above six markers provided 
coverage for only half of the chromosome. Moreover, the distribution of the six markers 
was not optimal because of a large interval of 22 cM between markers REN149M14 and 
FH2561.  
The most recent version of the canine map contains 3,300 markers at 1 Mb 
resolution (Guyon et al. 2003). That work included a description of Minimal Screening 
Set 2 (MSS2), which is comprised of 327 markers. To expedite linkage studies and 
positional cloning efforts, the MSS2 was multiplexed into chromosome-specific panels 
(Clark et al. 2004). To better characterize this chromosome and to be able to confirm or 
reject the possibility of a QTL, seven more markers from MSS2 were genotyped on the 
same 147 individuals. The coverage of CFA06 was extended to 74.4 cM by the addition 
of 3 markers at the right telomeric end of the chromosome. The coverage was also 
improved by adding 2 highly informative markers in the 22 cM interval between markers 
REN149M14 and FH2561. A complete description of the 13 markers is provided in 
Table 6. Interval mapping analysis was performed using the new data set and the plot of 
the F test statistic is shown in Figure 3C. The addition of the 3 markers at the telomeric 
end of the chromosome resulted in a peak definition for the left DI at 60 cM with an F 
test value close to the chromosome-wide significance threshold of 0.05. This result 
supports the presence of a QTL for this trait suggested by the previous analysis using the 
initial 6 markers.  
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Table 6. Location (cM), polymorphism information content (PIC) and number of alleles 
for 13 markers on CFA06 on the first 147 individuals and on the final 159 individuals 
from the cross breed pedigree. 
   n = 147 dogs n = 159 dogs 
Marker  cM PIC # allele PIC  # allele 
C06.636  0 0.13 3 0.13  3 
REN111L07  3.6 0 1 0  1 
FH3303  7.4 0.86 12 0.86  12 
FH2370  8.8 0.80 10 0.85  11 
FH2119  12.3 0.75 5 0.76  7 
FH2164  20.4 0.71 6 0.72  8 
REN149M14  23.4 0.54 3 0.54  3 
FH3933  27.5 0.73 8 0.73  8 
FH2734  35.2 0.66 4 0.66  4 
FH2561  45.5 0.81 9 0.80  11 
FH2576  60.6 0.81 13 0.81  13 
FH2525  67.1 0.62 7 0.62  7 
REN285H12  74.4 0.18 2 0.18  2 
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Interestingly, this analysis suggests a QTL at 28 cM on CFA06 for both left and 
right DLS score. A closer examination of the markers in this chromosomal region shows 
that the only marker available in this area from the initial set of 6 markers is not very 
informative (REN149M14), having only 3 alleles segregating in the population and a 
PIC of 0.54. This explains why the analysis with the first 6 markers showed no QTL 
present in this region. The addition of two highly informative markers at position 27 and 
35 cM (FH3933 with a PIC = 0.73 and FH2734 with a PIC = 0.66) revealed the presence 
of a QTL in this region. 
This work was expanded with the addition of 12 new BC individuals that were 
genotyped for all 13 markers. To determine whether this addition strengthens the data, 
interval mapping analysis was performed using all 159 individuals and the plot of the F 
test is shown in Figure 1D. The addition of 12 individuals increased the peak F-value for 
both left DI and right DLS score above the threshold of significance at α = 0.05 and 
refined the definition of the peak for the left DI.  
 These results suggest that a QTL is segregating on CFA06 for both the DI and 
DLS score. This example is a clear illustration of the increase in power to detect QTL 
obtained by careful correction of genotyping errors, by strategic addition of more 
markers to provide a better coverage of the chromosome and by addition of more 
individuals in the analysis.   
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Discussion  
Genotyping errors occur when observed genotypes do not reflect the true alleles. 
These errors arise from mistakes in data entry, sample mishandling or errors introduced 
by the genotyping process itself (Ewen et al. 2000; Ewen et al. 2000). Genotyping errors 
are detrimental to linkage analyses (Goldstein et al. 1997; Cherny et al. 2001); therefore, 
the identification of errors is necessary for accurate analysis of data. While it is 
recognized that large genotyping data sets will likely contain errors, and the inclusion of 
incorrect data can result in erroneous conclusions (Abecasis et al. 2001; Terwilliger et al. 
1990), little attention is generally given to correcting the identified errors. The cleaning 
of genotype data should be an integral and important component of a successful genome 
scan for QTL detection. Too often data editing is limited to identifying Mendelian 
inheritance errors and changing the markers with errors into missing values in order to 
be able to run the analysis. Described herein is the importance of detecting genotyping 
errors, even those with modest error rates. In our study, an error rate of 4.87% was 
detected following a whole-genome screen with 247 microsatellite markers on 147 dogs 
from a cross breed pedigree and was reduced to 1.07% with the use of an Allele 
Correction program. Correction of genotyping errors increased the detection power of 
linkage analysis and allowed detection of an underlying QTL on CFA06 that did not 
show initial evidence for harboring QTL.  
The increased informativeness of the markers in a cross breed pedigree is a major 
advantage of using a cross breed pedigree for linkage analysis of complex traits. 
Evidence for this in our pedigree is that there is an increase in proportion of markers 
  
46
with higher number of alleles in the F1 and BC/F2 generation compared to the two 
founder breeds. 
Fine mapping of putative QTL is time consuming and costly. Therefore, it is 
useful to exclude certain chromosomes and chromosomal regions with a high level of 
confidence. The marker set used in this study was chosen to provide optimal coverage of 
the canine genome. Even so, intervals between some markers exceeded 10 cM. Addition 
of more markers in these regions will improve the mapping resolution or result in a 
definite exclusion of these chromosomal regions for further fine mapping. Also, the 
addition of highly informative markers in a 22 cM interval on CFA06 allowed us to map 
a QTL at a chromosome-wide significance level of 0.05.  
One of the major issues when envisaging positional cloning of the mapped QTL 
is the poor mapping resolution that is typically achieved after the initial genome-wide 
screen. Confidence intervals for the location of the QTL are of the order of 20 to 30 cM 
and typically contain as many as 500 to 1,000 genes. This is due to the limited number of 
recombination events in the available pedigree, and the fact that many QTL effects are 
likely to reflect the combined action of multiple linked genes. The resolution of QTL 
mapping is limited by the information gained from observing the genotypic states of the 
markers (Darvasi et al. 1993). The observed recombinants can be limited by both small 
sample size and missing genotypic data. In one example, the addition of 12 backcross 
individuals increased the detection power of linkage analysis and helped to narrow the 
QTL region on CFA06.  
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In conclusion, by maximizing the information for QTL mapping, even in a less 
than optimum genome-wide screen, it is possible to detect putative QTL in dog 
pedigrees. This can be achieved by creating a cross breed pedigree which will result in 
increased marker informativeness. Detection and correction of genotyping errors is a 
crucial step in ensuring that maximum information is extracted from available data. The 
addition of additional markers in regions with poor coverage and addition of new 
individuals as they become available would also increase the power of the analysis.  
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CHAPTER V 
COMPREHENSIVE SCAN OF CHROMOSOMES HARBORING PUTATIVE 
QUANTITATIVE TRAIT LOCI FOR CANINE HIP DYSPLASIA 
 
Overview 
 Canine hip dysplasia (CHD) is a disease of the hip joint characterized by hip 
laxity and subluxation. CHD is widespread, affecting nearly every breed and more than 
half of the populations of several breeds. To investigate the genetics underlying CHD, an 
informative outcrossed pedigree was established using non-dysplastic Greyhounds and 
dysplastic Labrador Retrievers. Previously, a genome-wide scan using these kindred 
identified 12 chromosomes harboring putative quantitative trait loci (QTL). A 
chromosome-specific scan using multiplexed microsatellite markers was undertaken to 
further define and corroborate the identification of QTL involved in CHD. 
 
Introduction 
Canine hip dysplasia (CHD) is characterized by malformation of the hip joint. It 
predominantly affects medium and large breed dogs, but is present in almost all breeds. 
CHD is rare in sight hounds such as the Borzoi and the Greyhound, which are known for 
their tight hips (Todhunter and Lust 2003). CHD is generally a bilateral disease but can 
present unilaterally (Todhunter et al. 1997). The genetics underlying CHD are complex 
and several major and many minor quantitative trait loci (QTL) likely play roles in the 
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overall phenotype (Henricson et al. 1966; Leighton et al.1977; Hedhammar et al. 1979). 
Heritabilty estimates for CHD range from 0.11 to 0.68 (Bliss et al. 2002).  
There are several radiographic techniques that predict the development of CHD 
in young dogs based on hip conformation. The dorsolateral subluxation (DLS) test 
measures the percentage of the femoral head that is covered by the acetabulum while the 
dog is in sternal recumbency. An increased coverage increases the DLS score and 
represents a decreased probability of developing CHD (Farese et al. 1998). The DLS 
score is 83% sensitive and 84% specific (Lust et al. 2001). 
The PennHip method uses the distraction index (DI) to measure passive laxity in 
the hip. Specifically, the DI measures the distance of the femoral head from the center of 
the acetabulum divided by the radius (Smith et al. 1990). Scores generally range from 
zero to one, with a higher value indicating an increased joint laxity and therefore a 
higher probability of developing CHD. 
The Norberg angle (NA) is another indicator of subluxation that measures the 
angle of the femoral head in the acetabulum. A NA greater than 105° is considered 
normal. As the femoral head shifts out of the acetabulum, the angle decreases, indicating 
joint laxity (Morgan et al. 2000). 
Cornell maintains a pedigree of outcrossed Greyhounds and Labrador Retrievers 
(Todhunter et al. 1999). The pedigree was determined to have a power of 0.8 with an α 
level of 0.05 to detect QTL in a genome screen in the backcross generation using a 
single-marker, linkage-based simulation (Todhunter et al. 2003). In an effort to identify 
QTL involved in joint laxity and development of CHD, a whole-genome screen was 
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carried out at the Marshfield Clinic for Medical Genetics on 152 members of the 
designed pedigree (Todhunter 2005).  Twelve chromosomes harboring putative QTL, 
some with a protective effect and others that appear to worsen the phenotype, were 
identified (Todhunter 2005). 
The MSS-2 is the most comprehensive screening set of microsatellite markers 
now available for use in whole genome scans. The MSS-2 is comprised of 327 
microsatellite markers that have an average heterozygosity value of 0.73 and an average 
spacing of 9 Mb with no gaps larger than 17.1 Mb (Guyon et al. 2003). The MSS-2 has 
been multiplexed into 69 chromosome-specific panels to expedite whole genome screens 
(Clark et al. 2004).  
A scan utilizing the chromosome-specific panels of the MSS-2 to further define 
the 12 chromosomes harboring putative QTL identified by Todhunter et al. (2005) was 
carried out. Five additional chromosomes were selected that were suggestive of linkage 
but did not reach a significance level of p<0.05 (Todhunter, personal communication) or 
have been implicated in other work (Chase et al. 2004, Chase et al. 2005). 
 
Materials and methods 
MSS-2 reactions were set up as described by Clark et al. (2004) for the following 
chromosomes: 1, 2, 3, 4, 5, 7, 9, 10, 11, 12, 19, 25, 26, 29, 32, 37, and X. A total of 161 
markers were analyzed generating over 25,000 genotypes. Samples were resolved with 
an internal size standard (GeneScan 500 LIZ, PE Biosystems) using an ABI 3730 
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capillary-based Genetic Analyzer (PE Biosystems). Genotypes were analyzed using 
GeneMapper v 3.5 (PE Biosystems).  
Two-point LOD (Logarithm of the Odds) scores were calculated using a 
statistical software package (Sequential Oligogenic Linkage Analysis Routines, SOLAR; 
Southwest Foundation for Biomedical Research). SOLAR does not assume a mode of 
inheritance allowing the program to analyze the data for recessive, dominant and 
additive modes. The likelihood maximized by SOLAR is the normal. However, 
phenotypic traits are often not normally distributed. For that reason LOD scores were 
generated using both the log10 and the natural log (ln) of the likelihood ratio. LOD scores 
for each trait (DLS, DI, and NA) were calculated for the left and right hips separately. 
The markers included in the Marshfield screen were re-analyzed using the SOLAR 
program and are included in this work. 
 
Results 
LOD scores were calculated for 159 members of the Greyhound/Labrador 
Retriever pedigree. A significant LOD was not detected for any of the traits. All LOD 
scores greater than one are reported in Tables 7 and 8. Forty markers for different traits 
had a LOD between 1.0 and 2.0 when combining the log10 and ln analyses. Six markers 
with various traits had a LOD score between 2.0 and 3.0, with the highest score of 2.69 
located on CFA02 for marker FH2225. Interestingly, four of six markers on CFA29 had 
LODs greater than one for NA of the left hip. The markers with LODs greater than one 
did not change between the log and ln methods for this chromosome. One marker on 
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CFA30, REN50N18, has a LOD greater than one for both the DI and DLS traits in both 
hips (using the log data). All but 5 of the markers with LODs greater than one calculated 
with the log10 also had a LOD greater than one using the ln method. 
 
 
 
Table 7. LOD scores calculated with Log10 
Trait Chromosome Marker LOD 
CFA02 AHT132 1.57 
CFA02 FH2225 2.69 
CFA02 FH3006 1.26 
CFA20 CPH16 1.60 
DI - left 
CFA30 REN50N18 1.9 
CFA10 FH2537 1.56 DI - right 
CFA30 REN50N18 1.68 
DLS - left CFA04 FH2732 1.33 
 CFA05 CPH18 1.71 
 CFA07 REN97M11 1.23 
 CFA08 FH3316 1.01 
 CFA12 FH1040 1.14 
 CFA30 LEI-1F11 1.07 
 CFA30 REN50N18 2.07 
DLS - right CFA30 REN50N18 1.76 
NA - left CFA09 REN145P07 1.63 
 CFA29 CPH9 1.10 
 CFA29 FH2328 1.09 
 CFA29 FH2609 1.15 
 CFA29 REN45F03 1.31 
 CFA33 REN291M20 1.03 
NA - right CFA23 FH2626 1.07 
 CFA29 FH1007 1.35 
 CFA31 REN265M13 1.03 
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Table 8. LOD scores calculated with ln  
Trait Chromosome Marker LOD 
DI - left CFA02 AHT132 1.05 
 CFA02 FH2225 2.00 
 CFA02 FH3006 1.14 
 CFA02 REN70M14 1.03 
 CFA02 REN150M24 1.11 
 CFA07 VIASD10 1.53 
 CFA17 REN310J13 1.18 
 CFA20 FH2528 1.49 
 CFA23 FH2508 1.30 
DI - right CFA01 REN47D17 1.07 
 CFA10 C10.16 1.30 
 CFA10 FH2537 1.34 
 CFA10 REN06H21 1.09 
 CFA15 REN06C11 1.52 
 CFA31 REN265M13 1.16 
 CFA32 AHT127 1.99 
 CFA36 REN85C13 1.38 
DLS - left CFA04 AHT103 2.18 
 CFA04 FH2732 2.29 
 CFA05 CO5.377 1.15 
 CFA05 CPH14 1.89 
 CFA05 CPH18 2.38 
 CFA05 REN175P10 1.95 
 CFA08 FH3316 1.25 
 CFA12 FH1040 1.47 
 CFA18 AHT130 1.46 
 CFA20 FH2528 1.35 
 CFA29 REN52D08 1.57 
 CFA30 LEI-1F11 1.53 
 CFA30 REN50N18 1.97 
DLS - right CFA04 FH2732 1.27 
 CFA30 REN50N18 2.16 
NA - left CFA09 REN145P07 1.59 
 CFA29 CPH9 1.09 
 CFA29 FH2328 1.11 
 CFA29 FH2609 1.16 
 CFA29 REN45F03 1.29 
 CFA33 REN291M20 1.02 
NA - right CFA23 FH2626 1.06 
 CFA29 FH1007 1.34 
 CFA31 REN265M13 1.05 
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Discussion 
 In an effort to further define regions harboring QTL for CHD (Todhunter et al. 
2005) a chromosome-specific scan was carried out on a Greyhound/Labrador Retriever 
outcrossed pedigree. A statistically significant LOD score was not found for any 
markers. However, several areas of interest were highlighted. For example, Todhunter et 
al. (2005) identified a QTL on CFA29 with a p<0.01. A LOD higher than one was 
calculated for four of six markers on CFA29. It is possible that the use of multi-point 
analysis in which neighboring marker information is taken into account will boost the 
scores to a significant level. By normalizing the data using both the log10 and the ln, we 
expect to find the same regions highlighted. The log10 analysis overlapped the ln data 
almost completely (with the exception of 5 scores) indicating that these could be true 
markers segregating with the trait of interest.   
The scores show the value of using multiple traits to scan for a complex disease 
since several markers showed suggestive results with one trait but not another. SOLAR 
will be used to analyze the segregation of a low or high DI, DLS and NA in an effort to 
identify other putative QTL or corroborate interesting data we have generated thus far. 
Due to the special design of the outcrossed pedigree, other modeling techniques, 
such as QTL Express (http://latte.cap.ed.ac.uk/), that include the population structure as 
a fixed effect are being utilized for analysis of these data. Analyses of the remaining 
chromosomes not included in the initial screen and of a pure bred population of 
Labrador Retrievers, created with many of the same founders in the outcrossed pedigree, 
are also underway.   
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CHAPTER VI 
CONCLUSIONS 
 
The dog plays a role in so many facets of human society. They are hunters, 
protectors, and most of all our companions. Our laboratory’s main goal is to improve the 
quality of life for dogs. However, an important ancillary aim is to provide new insight 
into human diseases by dissecting the genetics of those hereditary diseases that affect the 
dog and human. The specific aims for this work are to develop an efficient genomic tool 
for use in whole genome screens and to identify genomic regions that are influential in 
the development of CHD. 
CHD is a complex disease that affects most breeds. Joint laxity is an important 
physical and genetic component of CHD (Henricson et al. 1966, Kealy et al. 1997). 
Radiographic methods that score hip conformation in young dogs, and therefore, predict 
the likelihood of later development of CHD have been based on measuring joint laxity in 
the hip (Smith et al. 1990, Farese et al. 1998, Morgan et al. 2000). There has been little 
success using selective breeding practices to minimize the incidence of CHD. The 
identification of genes that are involved in joint laxity and therefore CHD will allow 
breeders to screen for susceptible dogs prior to breeding.  
Chapter II describes the development of a tool for use in whole genome scans of 
the dog. A set of microsatellites was multiplexed into chromosome-specific panels 
(Clark et al. 2004). The MSS-2 is composed of 327 microsatellites that provide 9 Mb 
coverage of the canine genome (Guyon et al. 2003). Primers were labeled with 
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flurorescent dyes (6FAM, VIC, PET, NED) allowing co-resolution of markers. 
Labels were selected based on chromosomal location and product size to allow minimal 
overlap of products. Reactions were optimized for resolution on an ABI 3100 Genetic 
Analyzer. Sixty-nine chromosome-specific panels were developed for the MSS-2. This 
work reduces the number of necessary reactions by 68% and runs on a genetic analyzer 
by 76%. 
The multiplexed MSS-2 panels were used in a whole genome screen for joint 
laxity in the BS as described in Chapter III. Genotypes were generated for 28 BSs for 
254 of the MSS-2 markers. Laxity was measured using the DI from the PennHip 
method. Two-point LOD scores were calculated for each marker using SOLAR. The 
highest LOD score was for a marker located on CFA01, but did not reach statistical 
significance. Two methods to diagnose and predict future development of CHD were 
compared and found to be positively correlated. 
Chapter IV describes the power that can be gained by using a designed pedigree. 
The PIC for markers used in a whole genome scan of an outcrossed Greyhound/Labrador 
Retriever pedigree increased in the F1 and F2/BC generations. The need for stringent 
genotyping corrections is also shown. Using an Allele Correction Program, genotyping 
errors were reduced, allowing the identification of a putative QTL. Increasing genome 
coverage with additional markers allows for more opportunity to detect a QTL as well. It 
is also important to note that inclusion of new family members can increase the power of 
the pedigree to find an association with a QTL.  
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Chapter V describes a scan utilizing the chromosome-specific panels of the MSS-
2 to further define 12 chromosomes harboring putative QTL identified by Todhunter et 
al. (2005). Five additional chromosomes were selected that were suggestive of linkage 
but did not reach a significance level of p<0.05. LOD scores were calculated for 159 
members of the Greyhound/Labrador Retriever pedigree. Although none of the scores 
reached statistical significance, several indicated positive results in many of the same 
regions previously identified. Specifically, four of six markers on CFA29 had LOD 
scores greater than one for the NA of the left hip. The scores also show the utility of 
using multiple traits to scan for a complex disease since several markers showed 
suggestive results with one trait but not another. 
In summary, the goal of this work was to define the genetics underlying CHD, 
specifically joint laxity. In an effort to efficiently perform genome screens, a set of 
chromosome-specific multiplexes was developed. A full genome screen and a partial 
chromosome-specific scan were unable to identify statistically significant regions linked 
with the inheritance of CHD. Due to the special design of the outcrossed pedigree, other 
modeling techniques that take the population structure into account are being utilized. 
Analysis is now underway of the remaining chromosomes not included in the initial 
screen and of a pure bred population of Labrador Retrievers created with many of the 
same founders in the outcrossed pedigree.   
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